We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$178B
AUM Growth
+$29.6B
Cap. Flow
+$23.8B
Cap. Flow %
13.37%
Top 10 Hldgs %
19.53%
Holding
5,601
New
1,444
Increased
1,732
Reduced
1,786
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Consumer Discretionary 8.14%
3 Financials 7.71%
4 Healthcare 6.1%
5 Communication Services 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
5426
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-17,976
Closed -$67K
PRFT
5427
DELISTED
Perficient Inc
PRFT
-18,427
Closed -$1.39M
SWN
5428
DELISTED
Southwestern Energy Company
SWN
-91,420
Closed -$650K
GENE
5429
DELISTED
Genetic Technologies Ltd.
GENE
-15,100
Closed -$11.7K
TRVN
5430
DELISTED
Trevena, Inc.
TRVN
-3
Closed -$11
ONCT
5431
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-182
Closed -$240
VSTO
5432
DELISTED
Vista Outdoor Inc.
VSTO
-24,501
Closed -$960K
CMAX
5433
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
-182
Closed -$309
ENV
5434
DELISTED
ENVESTNET, INC.
ENV
-29,106
Closed -$1.82M

Similar funds

BNP Paribas Financial Markets's Q4 2024 Portfolio in Review

As of Q4 2024, BNP Paribas Financial Markets held 5,601 positions worth $178B, up 20% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

BNP Paribas Financial Markets deployed $23.8B of net new capital in Q4 2024, opening 1,444 new positions and adding to 1,732 existing holdings. Its largest new stake was GE Aerospace: 4,486,125 shares worth $748M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $362M trimmed.

  • BNP Paribas Financial Markets's largest Q4 2024 buy was GE Aerospace: 4,486,125 shares worth $748M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.7B increase.
  • BNP Paribas Financial Markets's biggest Q4 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $362M.
  • BNP Paribas Financial Markets fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2024, selling an estimated $34M.
  • BNP Paribas Financial Markets's ten largest holdings make up 20% of its $178B portfolio in Q4 2024.
  • BNP Paribas Financial Markets opened 1,444 new positions and closed 206 in Q4 2024.
  • BNP Paribas Financial Markets's portfolio value rose 20% quarter-over-quarter to $178B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.